Related Experiment Video
Updated: Apr 26, 2026

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
Published on: June 13, 2019
Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and
Koshiki Mino1, Satoshi Nishimura, Shogo Ninomiya
1a Graduate School of Bio-Science , Nagahama Institute of Bio-Science and Technology , Nagahama , Japan.
Abstract:
Tissue factor pathway inhibitor-2 (TFPI-2) is a major inhibitor of extracellular matrix degradation. Decreases in TFPI-2 contribute to malignant tumor cell production, and TFPI-2 is a presumed tumor suppressor. TFPI-2 gene transcription is regulated by two epigenetic mechanisms: DNA methylation of the promoter and K4 methylation of histone 3 (H3). Lysine-specific demethylase 1 (LSD1) and LSD2 demethylate H3K4me2/1. LSD1 has been implicated in TFPI-2 regulation through both epigenetic mechanisms, but the involvement of LSD2 remains unknown. We prepared a monoclonal anti-LSD2 antibody that clearly distinguishes LSD2 from LSD1. Knockdown of LSD1 or LSD2 by siRNAs increased TFPI-2 protein and mRNA. Simultaneous knockdown of both LSD1 and LSD2 showed additive effects. Bisulfite sequencing revealed that CpG sites in the TFPI-2 promoter region were unmethylated. These results indicate that LSD2 also contributes to TFPI-2 regulation through histone modification, and that further studies of the involvement of LSD2 in tumor malignancy are warranted.
Insights
Tissue factor pathway inhibitor-2 (TFPI-2) suppresses tumors by inhibiting matrix degradation. New research shows Lysine-specific demethylase 2 (LSD2) also regulates TFPI-2, suggesting a role in cancer.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Tissue factor pathway inhibitor-2 (TFPI-2) is a key inhibitor of extracellular matrix degradation and a presumed tumor suppressor.
- TFPI-2 gene transcription is epigenetically regulated by DNA promoter methylation and histone 3 lysine 4 (H3K4) methylation.
- Lysine-specific demethylase 1 (LSD1) is known to regulate TFPI-2, but the role of LSD2 is unclear.
Purpose of the Study:
- To investigate the involvement of LSD2 in the regulation of TFPI-2.
- To determine if LSD2 affects TFPI-2 expression through epigenetic mechanisms.
- To compare the roles of LSD1 and LSD2 in TFPI-2 regulation.
Main Methods:
- Preparation of a monoclonal antibody to specifically detect LSD2.
- siRNA-mediated knockdown of LSD1 and LSD2 in cells.
- Measurement of TFPI-2 protein and mRNA levels.
- Bisulfite sequencing to analyze DNA methylation of the TFPI-2 promoter.
Main Results:
- siRNA knockdown of either LSD1 or LSD2 individually increased TFPI-2 protein and mRNA levels.
- Simultaneous knockdown of both LSD1 and LSD2 resulted in additive increases in TFPI-2 expression.
- TFPI-2 promoter CpG sites were found to be unmethylated, indicating regulation via histone modification rather than DNA methylation.
- The anti-LSD2 antibody successfully distinguished LSD2 from LSD1.
Conclusions:
- LSD2, similar to LSD1, contributes to the regulation of TFPI-2 through histone modification.
- These findings highlight a novel epigenetic regulatory pathway for TFPI-2.
- Further research into LSD2's role in tumor malignancy is warranted.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway
Master Transcription Regulators
TGF - β Signaling Pathway
Epigenetic Regulation
X-chromosome...
Regulation of Expression at Multiple Steps

